Tryton Medical, Inc. recently announced the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) application for the Tryton Side Branch Stent for the treatment of coronary bifurcation lesions involving large side branches (appropriate for a ≥2.5mm stent). The Tryton Side Branch Stent is the first dedicated bifurcation device to receive regulatory approval in the U.S.

Coronary artery disease (CAD), the leading cause of death in the U.S. in both men and women, often results in the buildup of plaque at a site where one artery branches from another, also known as a bifurcation. Approximately 20-30% of all patients undergoing percutaneous coronary interventions (PCI) to open blocked arteries have a bifurcation lesion. Provisional stenting of the main branch is the current standard of care, but in many cases the side branch is not stented, leaving it vulnerable to complications like occlusion requiring bailout stenting.

“It is estimated that nearly a third of all patients treated with angioplasty each year have a bifurcation lesion, and the standard provisional treatment approach leads to side branch occlusion and bailout stenting far too often,” said Shawn McCarthy, President and CEO of Tryton Medical. “With this first-of-its-kind approval in the U.S., interventional cardiologists now have access to a stent that is specifically engineered to provide the complete lesion coverage and more predictable patient outcomes needed for the challenging anatomy of coronary bifurcation lesions.”

In a post hoc analysis of a randomized investigational device exemption (IDE) clinical trial, treatment with the Tryton Side Branch Stent in the intended population of patients with large side branches (appropriate for a ≥2.5mm stent) reduced the need for additional bailout stenting (0.7% vs. 5.6%, P = 0.02) and led to statistically significant lower side branch percent diameter stenosis at nine month follow up (30.4% vs. 40.6%, P = 0.004) when compared to provisional stenting. The post hoc analysis also showed comparable major adverse cardiovascular events (MACE) and myocardial infarction (MI) rates versus provisional stenting at three years.

The safety profile of the Tryton Side Branch Stent was validated in a confirmatory study that compared patients treated with the Tryton stent to a performance goal based on performance of the control arm from the randomized IDE clinical trial. The confirmatory study met its pre-specified primary endpoint, periprocedural myocardial infarction (PPMI), which was within its non-inferiority margin (Primary Endpoint: 10.5% + 95% C.I. vs. 17.9%, p=0.01).

“Treatment of complex lesions at the site of a bifurcation has historically been inconsistent, with results varying depending on the procedure and the experience of the interventionist,” said Aaron Kaplan, MD, Professor of Medicine at Dartmouth Hitchcock Medical Center and Chief Medical Officer of Tryton Medical. “A predictable bifurcation solution helps alleviate some of the stress in these procedures by limiting variability and reducing the need for bailout stenting. This important FDA decision could have a profound impact on treatment protocols and guidelines for significant bifurcation lesions in the years ahead.”

Tryton has signed a strategic distribution agreement with Cardinal Health enabling Cordis, its interventional vascular business, to be the exclusive distributor of the Tryton Side Branch Stent in the U.S. “This strategic agreement is a significant step for Cordis to quickly get innovative technologies into the hands of our customers in the U.S. We are actively preparing to commercially launch this product with Tryton to ensure physicians will soon have a new treatment option in their cath labs to help deliver the best patient care available,” said David Wilson, President of Cordis.

The Tryton Side Branch Stent is available in multiple device diameters (2.5mm to 3.5mm in the side branch) and is compatible with any conventional drug eluting stent in the main vessel.

For Further Information
More on the diagnostic coronary catheter and guidewire market in the U.S. can be found in the report published by iData entitled U.S. Market for Interventional Cardiology Devices. This report also covers the U.S. market segments for bare-metal and drug-eluting stents, PTCA and cutting balloons, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion crossers, introducer sheaths, coronary vascular closure devices, diagnostic coronary catheter and guidewires, intravascular ultrasound catheters, and optical coherence tomography catheters.

The iData series on the market for interventional cardiology devices covers the U.S., Japan, Brazil, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about U.S interventional cardiology market data or procedure data, register online or email us at [email protected] for a U.S. Market for Interventional Cardiology Devices report brochure and synopsis.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Categories

Social Links

?Want more information about the market report mentioned in this article?

Subscribe to iData News

We publish medical, dental, and pharmaceutical news and market insights from our analysts every day. Sign up for your free subscription here:

Leave this field empty if you’re human:

What we do

iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

Social Links

FREE Report Download

Ulcerative Colitis Drugs Market in the United States 2018 - 2023

Special Limited Time Giveaway:
Register to download a full report on the United States market for Ulcerative Colitis drugs (Valued at over $3000 with market values, competitor shares, annual drug cost and much more). This is one full section from the global package which covers 12 countries and 5 immunology diseases.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

FREE Report Download

Global Cardiology Survey Results

This 63-page report covers hundreds of survey responses from 59 different countries. Gain insight into these top cardiology product preferences and decision reasons to improve your marketing strategy.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

FREE Report Download

Global Orthopedic Surgeon Survey

This 44-page report covers hundreds of survey responses from 37 different countries. Gain insight into these top orthopedic physician product preferences and decision reasons to improve your marketing strategy.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

Login

FREE Whitepaper Download

The State of the US Dental Market

This free whitepaper is your entrance point to knowledge about the dental market in the United States. This analysis covers the major market values and growth trends for 9 different markets and provides the leading competitors in each.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

Ultimate Guide to Buying

Medical Market Research [Free Download]

Discover the secrets to comparing medical market research firms and how to confidently choose one that fits your needs.
These 11 simple questions
to ask will help you investigate your potential research partners and ensure you make the right decision the first time.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.